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Chapter 1 General Introduction 
1.1 Basic Bone Biology and Regeneration  
Bone is a highly mineralized connective tissue that is able to support human body and 
maintain mineral homeostasis[1]. Macroscopically, bone tissue can be classified into compact 
bone (cortical bone) and spongy bone (trabecular bone)[2]. Compact bone is mainly responsible 
for supporting and protecting. It is formed by plenty of osteons with longitudinal Haversian canal 
passing through the center[2]. And each osteon is connected by Volkmann’s canal. The 
Haversian canal and the Volkmann’s canal form the network for bone’s nutrition supply and 
signal transduction[1, 2] 
 Spongy bone is a light weight, highly porous tissue where riches in blood vessel and 
contains bone marrows. Usually it locates inside of compact bone or at both ends of long bone. 
The unit structure of spongy bone is trabecula. The main blood vessel, lymphatics and nerve 
fibers go through the center of spongy bone. Red bone marrow full filling pores of the spongy 
bone. Therefore, the spongy bone has the function of supply nutrition for bone cells, 
hematopoiesis, and keep mineral balance in body. The coating of bone is named periosteum 
which is a highly vascularized connective tissue. Not only can it connect one bone tissue with 
anther or with muscle tissue, but also has the ability to produce bone during body development 
and bone healing because amounts of bone cells accumulate at inner layer of periosteum [3, 4]. 
The extracellular matrix of bone tissue is different from other connective tissue, because 
it is highly mineralized. It contains 65% of inorganic matrix and 35% of organic matrix[2]. The 
major component of minerals matrix is hydroxyapatite [Ca10(PO4)6(OH)2]. The organic matrix is 
composed of type one collagen and more than 200 kinds of noncollagenous proteins, such as 
fibronectin, osteopontin and osteocalcin [2]. This kind of organic matrix is important for bone 
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cells adhesion, proliferation, differentiation, accumulation and signal transduction of growth 
factor. 
There are several types of bone cells related to the bone remodeling, such as 
mesenchymal stem cells (MSCs), osteoblasts (OB), osteocytes (OC), osteoclasts, and 
chondrocytes[1]. The mesenchymal stem cells located in bone marrow are small, long and thin 
cells with large nucleus[5]. They have great capacity of self-renewal and can differentiate into 
adipocytes, chondrocytes, osteoblasts, adipocytes, hepatocytes, and pneumoncytes. In the 
vascularization area, the mesenchymal stem cells would differentiate into osteoblasts; while they 
are under the non-vascularization area, they would form chondrocytes [2, 5-7]. The osteoblasts, 
immature bone cells, produce osteoid matrix which is mainly composed of type I collagen, 
alkaline phosphatase, and other proteins [8]. After osteoblasts are trapped and deposit in the bone 
matrix, they eventually develop to mature bone cells, osteocytes. Like osteoblasts, the osteocytes 
can secrete hydroxyapatite, calcium carbonate and calcium phosphate bone matrix[2, 8].Besides, 
they are very sensitive to mechanical strain and can also secrete many growth factors to help 
cells proliferation and differentiation. Chondrocytes originated from mesenchymal stem cells are 
related to cartilage formation [9]. The osteoclasts are large and multinuclear cells which is 
important for bone degradation and re-sorption. There are several specific cell markers for 
osteoclasts like Receptor Activator of Nuclear Factor κ B (RANK) [2]. It also can be regulated 
by many hormones such as parathyroid hormone and calcitonin [2].If there are some imbalances 
between these factors, it can lead to several diseases like osteoporosis. Therefore, it is important 
to keep the equilibrium between bone formation and bone re-sorption. 
Many growth factors and transcription factors participate in osteogenesis such as bone 
morphogentic proteins (BMP), Cbfa/Osf2, alkaline phosphatase (AKP), fibroblast growth factor 
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(FGF) and vascular endothelial growth factor VEGF [1,2, 10-12]. For example, BMP is pivotal 
for bone building, remodeling, and healing. So far, BMP have been classified into 7 types. 
Generally, BMP through binds to bone morphogentic protein receptor (BMPR) leading to BMPR 
phosphorylated which would cause cascade phosporylating sub signaling protein such as Smad1 
to transduce bone formation information[2]. Because BMP can instruct MSCs differentiate into 
chondrocytes and osteoblast to form cartilage and bone, it provide an potential function for many 
pathological treatment such as BMP defection disease, spinal fusion, bone fracture surgery, and 
bone regeneration. Alkaline phosphatase is an enzyme and more effective in an alkaline 
environment to dephosphorylate these phosphorylated proteins. It is the by-product of osteoblasts. 
It can be tested in blood as an indicator of osteoblasts activity. While it is at high level of blood, 
bone may be under growth situation. However, if it is quite high which may also mean some 
disease occurs like chronic myelogenous leukemia, it is a pretty lower level can lead to bone 
deformities. 
Intramembranous ossification mainly responsible for forming skull and flat bones[2]. 
During the intramembranous ossification, neural crest-derived mesenchymal cells recruited by 
BMPs, cytokines and α-TNF family accumulate around vascularized area, and proliferate 
forming condense nodules. Then these mesenchymal cells differentiate into osteoblasts. 
Osteoblasts, bone forming cells, secrete a collagen-proteoglycan matrix which is able to bind 
calcium salt. The osteoid matrix induces more and more mesenchymal cell aggregating and 
differentiating around it, as a result, more and more osteoblasts deposit around the osteoid matrix. 
Some osteoblasts are entrapped into the matrix and develop to mature bone cell—osteocytes 
accidentally. As calcification proceeds, bony spicules formed. With the spicules growth, 
mesenchymal cells and osteoblasts still deposit into the spicules. Furthermore, spicules located 
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closely fuse together form the trabecula. The trabecula network is called woven bone which is 
characterized by haphazard organization of collagen fibers and is mechanically weak[6]. Later 
the entire region of woven bone is surrounded by periosteum originated from mesenchymal cells. 
In inner side of periosteum, osteoblasts continue secrete the osteoid matrix and develop to 
osteocytes. Therefore the layers of bone formed. Besides, the previous vascular area is developed 
to Haverian canal. 
The secondary bone formation process is called endochondral ossification[2]. It first 
forms cartilage following replaced by osteoblast to form sponge bone. The whole process can 
divided into five steps. Firstly, MSCs aggregate and differentiate into chondrocytes with the help 
of lots growth factors, and chondrocytes form cartilage model. Secondly, because of little blood 
vessels in these non-vascularized areas and the growth of cartilage model, these chondrocytes are 
under hypertrophic environment which would lead to the apoptosis of chondrocytes. Thirdly, the 
formation of the first ossification center, as the apoptosis of chondrocytes, arteries enter into 
diaphysis which would bring osteoblasts and osteoclasts. With the entrance and growth of 
osteoblasts, they would form trabecular, and eventually create sponge bone by secreting osteoid 
and mineralizing cartilaginous matrix. For osteoclasts, they degenerate cartilaginous matrix 
under the regulation of two hormones, parathyroid hormone (PTH) which release calcium into 
blood and calcitonin which bring calcium back to bone, to form medullary cavity in the center of 
the diaphysis. Fourthly, when these blood vessels enter the end of each bone, the secondary 
ossification center occurs in epiphysis. The secondary ossification center goes through the same 
process as the first ossification center to form sponge bone. The secondary ossification center 
can divide into six zones. The zone of reserve cartilage is a hyaline cartilage zone contains lots 
small cells; in the zone of cell proliferation (ZP), chondrocytes cells are also small and arrange in 
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columns which have strong mitotic activity[2]; in zone of cell and lacunar maturation and 
hypertrophy enlargement (ZH), chondrocytes grow, have a larger size than them in ZP, and go 
through apoptosis process; in zone of calcification (ZC), chondrocytes die and mineralizing bone 
matrix which can use basophilic staining to distinguish it with other zones; zone of cartilage 
removal and bone deposition is among ZC. The last step is the articular cartilage and epiphyseal 
plate form. This place is very sensitive to cushion and allows the bone to continue growth of 
sponge bone in adults. 
1.2 Musculoskeletal disorders and injuries 
Nowadays, several hundred million patients suffered from musculoskeletal disorders and 
injuries all around world, and this number may be double by 2020 as ageing[2].In United State, 
50% of the people aged over 65 are suffered from chronic joint disease. And half of women and 
a quarter of men aged over 50 will experience osteoporotic fractures[2] which account for three 
hundred thousand hip fractures, seven hundred thousand vertebral fracture and other fractures. It 
will directly cost 18 billion in treatment. In addition, a large number of severe bones defects will 
be caused by war and accident per year. Furthermore, other musculoskeletal diseases such as 
spinal disorder, osteoporosis, osteoarthritis and cancers will impact bone’s function. Moreover, 
the bone disorders become more and more severe as the obesity and ageing. Therefore, bone 
regeneration strategies have attracted attention. 
1.3 Current Bone Regeneration Strategies 
Traditionally, the bone regeneration therapies are autologous or allogeneic 
transplantations and treat by metals or bone cements [13-15] . Autologous transplantation applies 
bone substitutes sourced from a patient’s own bones in order to supply mechanical strength and 
maintain ostergenesis, osteoinduction and osteoconduction in bone defect[16]. The autografts are 
the ideal bone grafts, but it is limited by supply and pain and /or morbidity in harvest site [15, 
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17].The morbidity after orthopedic surgery using  an autograft from the iliac crest is close to 
30%[18]. Furthermore, the expenditure of this surgery is expensive[17]. And usually, patients 
need receive a long time of medical care after the surgery. 
In order to overcome the drawbacks of autografts, allografts, donated from other people, 
have been widely applied. For example, recent years, more than a million allografts were 
transplanted in bone injured individuals[2]. The allografts with various shape and size satisfy the 
requirement of the bone grafts. In addition, the patients no longer need to suffer from the 
compliments of harvest site. Nevertheless, the amount of allografts still cannot satisfy the need. 
Moreover, the allografts transplantation may potentially transmit diseases from the donors. The 
grafts’ quality, mechanical strength, osteogenesis, and osteoinduction, also are impacted after 
serializing and freezing proceeds [2, 16, 17]. 
Tissue engineering may be a promising solution to overcome these drawbacks for the 
bone regeneration strategy. It combines the principle of life science and engineering to induce 
bone tissue regeneration[19]. The bone tissue engineering involves three factors: cell, bone 
scaffold and bioactive agents[20]. The bone scaffolds mimicking nature bone structure integrate 
with bioactive agents to stimulate cell growth, vasculature and nerve formation [2, 21]. 
Consequently, it is able to promote tissue regeneration and sustain the mechanical stress during 
bone regeneration[21]. 
1.4 Bone graft  
The artificial bone graft is a significant factor in tissue engineering. Structure, materials 
and fabrication techniques can decide the properties of bone scaffold. An ideal bone scaffold 
should be non-toxic at least[2]. Before usage, the scaffolds need to be sterilized. Meanwhile, 
biocompatibility is second requirement for an ideal bone scaffold.  The bone scaffold with good 
biocompatibility can avoid undesired rejection by host tissue[22]. Usually, the biocompatibility 
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of bone scaffold can be interpreted at three levels: (1) Blood protein interaction[23]. After 
implantation, the scaffold contacts with the blood protein firstly. This interaction can affect cell 
attachment and host response to the scaffold [23, 24]; (2) Local host response. The bone scaffold 
will be degraded through corrosion [25, 26], hydrolysis [27, 28], as well as enzymatic reaction. 
As a result, degradation products may induce unwanted response like inflammation and 
immunological reaction at the transplant site[29]; (3) Systemic effect. If the degradation products 
were not eliminated, it would transport to whole body through circulation, and cause severe 
immunological response[29]. Therefore, the biocompatibility can lead the grafts to succeed or 
failure. In addition, not only the material of scaffold should be biodegradable, but also the 
degradation rate should keep in the similar speed with bone remolding rate. Since the scaffold 
can temporally provide the bone’s function until the new bone formed. Moreover, the bone 
scaffold should be a poriferous structure. Since porosity, pore size and pore interconnection of 
the scaffold closely relates to cell attachment, osteogenesis and mechanical strength [30, 31]. A 
scaffold with larger pore size, higher porosity and pore interconnection is benefit to nutrition and 
oxygen transportation and cell ingrowth. Previous research showed that osteogenesis occurs at 
the area with large pore size (>350µm) and high porosity in vivo [32]. They also found that 
capillary cannot grow inside the pore with the size less than 200µm [32, 33]. As a result, these 
areas usually proceed chondrogenesis. Besides, the larger pore size, higher porosity and pore 
interconnection result the roughness surface of scaffold which improve cell attachment, 
proliferation and differentiation. However, this structure impacts the mechanical strength and 
increase the biodegradation rate. In conclusion, a good bone scaffold should have appropriately 
porosity to maintain the balance between osteogenesis and mechanical strength. Furthermore, as 
mentioned above, the bone scaffold should sustain mechanical loading. The mechanical strength 
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of nature bone relates to harvest site, gender, age, sample preparation and test environment. So it 
is difficult to decide the bone strength. Generally, the spongy bone can bear 2-12MPa strength, 
and the cortical bone can stand 200MPa [34]. Overall, a desired bone scaffold should mimic the 
nature bone structure and properties [35]. 
Bone grafts materials can affect biocompatibility, degradation rate and osteogenesis 
process. Generally, materials can be classified into three types: natural polymer, synthesis 
polymer and ceramics. Natural polymers, like collagen, chitosan and hyaluronan, are designed to 
mimic bone extracellular environment[36]. They have desired biocompatibility and can interact 
with cells[36]. And they are biodegradable but the degradation rate is difficult to control[36]. 
The more important is that the mechanical strength of this scaffold is weak. The second type of 
the material is synthesis polymers, such as PCL, PLA, PLA-PEG and PLGA. The degradation 
rate and mechanical properties are easier to control for this type material through change 
chemical bonds as well as the repeat units of polymer[2]. However, the degradation products are 
toxic sometimes which may cause inflammation and immulogical response[2].  
The last type of material is ceramics which mimics the mineral composition of nature 
bone[37]. In general, the ceramics scaffolds can stand high mechanical loading and have good 
biocompatibility [37, 38]. The extensively used ceramics materials are hydroxyapatite (HA), 
tricalcium phosphate (TCP), bioactive glasses, and mixed calcium phosphate (MCP, mixed by 
HA and TCP) [39]. As the bone substitute materials, they can be applied in particulate and bulk 
form. For instance, HA has similar chemical structure and crystallography with carbonated 
apatite in nature bone. It is also the maximum inorganic component in ECM of bone tissue. HA 
can be used as particulate to fill the defects with irregular shape, like dental implantation. 
Simultaneously, it is used as bulk form when replacement of defected bone caused by trauma or 
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disease is need. The major drawback of these materials is comparatively low strength properties. 
Some researchers found that the mechanical strength of HA and TCP scaffold were less than 
2MPa and without any strength in tension [40, 41]. Besides, the degradation rate is hard to 
control. For example, Hench LL et al. discovered that the degradation rate of HA was much 
longer than the bone growth rate which was not benefit to osteoinduction and osteoconduction 
[42]. Consequently, better bone grafts materials should be investigated for satisfied requirements. 
Chapter 2 Physiochemical characterization of gradient vs. homogenous SCPP scaffolds 
2.1 Introduction 
2.1.1 Calcium polyphosphate as bone grafts material 
Recently, more and more attentions have been focused on calcium polyphosphate, 
because it shows controllable biodegradation, desired biocompatibility and better mechanical 
strength. Calcium polyphosphate (CPP, [Ca(PO3)2]n) has lower Ca:P ratios (0.5) than HA ( Ca : 
P=1.67) and TCP (Ca:P=1.5) [39]. Therefore, CPP with low Ca:P ratios can forms a chain-like 
polymer which is linked by oxygen bridged phosphate tetrahedral [39, 43] (Figure 1). Each 
bridging oxygen atoms within the CPP structure represent a possible center for hydrolysis. The 
degradation product is calcium orthophosphate, a naturally occurring metabolizable substance. 
That is the reason for its good biodegradation and biocompatibility. Additionally, the CPP can 
bear higher mechanical loading than other calcium phosphate materials. Pilliar et al. reported that 
a CPP scaffold with 30% porosity can stand 24.1MPa strength during compression test [39].  
Many researches have investigated the potential application of CPP for bone tissue engineering. 
The first reported research was using CPP to replace the defect in rat femurs[44]. Researchers 
found no adverse host response to implanted CPP scaffolds 4 weeks after [44]. Later other 
research group used the CPP to restore mandibular crestal bone in dogs[45]. 4 months later, after 
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sacrifice, they found that compared with autografts the CPP scaffolds significantly stimulated the 
bone ingrowth. In conclusion, the CPP could be a suitable material for bone substitute.   
2.1.2 Gradient porous bone scaffold 
Conventionally, the bone scaffolds have a uniform/ homogenous structure, dense 
structure or porous structure. However, as we know, nature bone is not a uniform tissue which 
consists of spongy bone and cortical bone with different pore size and porosity. For this reason, 
functional gradient scaffolds have been designed and studied about twenty years. The gradient 
scaffolds are purposely designed with continuous change microstructure [46]. The pore size, 
porosity and interconnectivity can be all graded throughout of the scaffold. According to 
application, the gradient scaffold can be formed in different shapes. For example, it can be 
cylindrical with dense core and porous layers which is able to stand high mechanical strength 
[46]; also it can be rectangular which have dense bottom-porous top or porous top-dense center 
and bottom[46]. 
Comparing to homogenous scaffold, one of the advantages of the gradient structure is 
functional layers. Dense bone scaffold has high mechanical strength but is not good for bone 
ingrowth; while the porous scaffold benefits bone in growth but has weak mechanical strength. 
So the gradient scaffold can overcome the drawbacks of these scaffolds. Since porous layers are 
suitable for cell attach and growth; dense layers have high mechanical strength. Besides high 
interconnectivity on porous layers performs the function of vascular canals in bone tissue which 
benefit to nutrition transport. In addition, the grade pore size benefits to grow different types of 
cells and form different tissues. For example, the chondrocyte prefers grow on the area with pore 
size from 70 to 120 µm; and bone regeneration usually happens on larger pore size (100-400 µm) 
[47]. In general, the gradient scaffold provides different microenvironment for various cells 
ingrowth. The gradient structure also is better to match the bone growth rate. Porous layer allows 
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the initial bone ingrowth, and later the longer time remodeling will happens on the layer with 
small pore size. 
2.1.3 Fabrication of gradient scaffold 
The processing methods for homogenous scaffolds fail to apply on gradient scaffold 
completely. Thus, fabrication of gradient scaffolds is a new challenge. Currently, several 
methods have been developed, such as vacuum infiltration, pulsed electric current sintering, 
pressure filtration of mixed particles, electrosparying, centrifugation of suspension and freeze 
drying, etc. [46].Some of them are able to fabricate graded pore size, but unable to form good 
interconnectivity and porosity; others may enable to form good interconnectivity and high 
porosity, but fail to control the structural regularity. For example, the pressure filtration of mixed 
particles usually applied to make graded hydroxyapatite scaffold. It mixes hydroxyapatite slurry 
with a compositional gradient carbonaceous particle suspension during filtration process. The 
dried and consolidated mixture is sintered, forming a gradient porous scaffold. This method can 
control the porosity, but fail to form a gradient pore size structure and high interconnectivity 
because the carbonaceous particles are in uniform size [48]. The elctrospraying method can form 
the gradient scaffold with high porous interconnectivity. It can use ceramic droplet such as 
hydroxyapatite to pass through an electric field and to deposit on a porous template like 
polyurethane sponge [49]. After that, the ceramic structure is sintered to burn off the template. 
The limitation of this method is uncontrollably regular structure.  
In the first part of this study, we developed a novel fabrication method of gradient 
scaffold CPP scaffold, gravity sintering. We mixed and compressed finely grounded amorphous 
calcium polyphosphate granules with porogen, stearic acid, with gradient size in solid form. And 
later the scaffolds were sintered in a furnace for 8 hours and 20 minutes in order to evaporate the 
stearic acid and form the gradient pores. Based on the principle of fabrication, this method can 
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control pore size, porosity, and porous distribution and should have good interconnectivity. In 
order to testify this novel fabrication method and to study the gradient scaffold, the properties of 
these scaffolds were studied to determine how the distribution and variation of porosity affects 
the structure of the scaffolds compared to homogeneous scaffolds. 
2.2 Materials and Methods 
2.2.1 Materials 
Calcium phosphate monobasic monohydrate (Ca(H2PO4)2.H2O), Serial acid, PVA 
solution (15%, w/v, Mw 70,000), calcein were obtained from Sigma-Aldrich (USA), Sodium 
EDTA and Muffle furnace were from Fisher Scientific (USA). Microplate reader was obtained 
from BioTek (USA). Manual pellet-press was from Carver (USA), SEM was purchased from 
Hitachi S-2400 (Japan), Gold Sputter was from Effa Coater (USA), MicroCT (Scanco Viva CT 
40) was from Scano Medical (Switzerland). Universal servohydraulic test machine was from 
Instron (USA) 
2.2.2 Preparation amorphous calcium polyphosphate (ACPP) granule 
The amorphous calcium polyphosphate (ACPP) originated from the calcium phosphate 
monobasic monohydrate through calcining procedure. Briefly, around 100g the calcium 
phosphate monobasic monohydrate was pressed into a 100ml ceramic cup and put into a furnace 
for calcining. The procedure of calcining was as followed: (1) temperature in the furnace 
increased to 500ºC in 40mins; (2) material was calcined at 500ºC lasting 10h; (3) temperature 
increased to 1200ºC in 30mins; (4) material stayed and melted for 1 h at 1200ºC. After that, the 
melting material was poured on ice immediately, which called ice squash. Since the temperature 
falling down quickly, the crystallization process of the material was not complete.  Finally, the 
ACPP products were harvested. The ACPP crystal were manually grounded and sieved into 
ACPP granule with the particle size less than 75µm. 
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2.2.3 Preparation of Gradient and Homogenous scaffold  
Basically, the scaffold was made through sinter method. For gradient scaffold, the finely 
grounded ACPP powder (<75µm) was mixed with four gradient sizes of stearic acid, which was 
used as porogen and would be evaporated at high temperature, the size of stearic acid x>300µm, 
300>x>250 µm, 250>x>75 µm and x<75 µm. The ratio of ACPP to stearic acid was 4:3 (Table 
1). The four gradient layers of material were pressed into a cylindrical tube respectively and were 
compressed under a loading pressure of 70 tons. At the last, the scaffold was sintered by furnace 
for 8 hours and 10 minutes. The gradient scaffold in cylindrical shape with1cm diameter and 
with 0.9 cm height was made (Figure 2). 
For the homogenous scaffold, the procedure was the same. The only different step was 
when adding the material into the cylindrical tube make sure the four layers’ material were mix 
evenly.  
The sinter procedure was as followed:  
100°C                300°C                300°C                800°C               800°C                 cooling down 
at room temperature; Since the materials were cooling down naturally, the crystallization process 
was completed. Thus the ACPP was formed to crystal CPP which has higher mechanical strength. 
2.2.4 Investigate the structural properties of Gradient and Homogenous scaffolds 
The structure properties were tested by MicroCT and SEM. Each scaffold was scanned 
with the Scanco VivaCT 40 using a voltage of 55 kVp and a current of 145 uA at 10um 
resolution. A cylindrical volume of interest was selected (100 slices) for each of the four layers 
within the gradient scaffold and 400 slices were selected for the homogeneous scaffold. An 
optimal threshold of 370 was determined. The morphology of the scaffolds was determined using 
software from the manufacturer to measure the average wall thickness (Tb.Th), average pore size 
(Tb.Sp), porosity, pore size distribution and interconnectivity. 
30min 3 h 100min 3 h 
Over night 
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Additionally, each gradient and homogenous scaffold was gold-coated by using Sputter 
coater. Morphologies were viewed by SEM at the operation of 25kV accelerating voltage. 
2.2.5 Mechanical Properties 
Unconfined, uniaxial compression test was applied to test the mechanical strength by 
universal servohydraulic test machine. The maximum deformed strain was 0.5 with the 
compression speed of 0.01mm/s. The maximum mechanical strength=maximum force/ the cross 
section area of scaffold. Each sample was set in triplicate. 
2.2.6 In vitro degradation study 
In vitro degradation study was measured by released Ca
2+
 concentration.  The scaffolds 
were incubated in PBS at 37ºC for sixteen days separately. Aliquots of PBS were collected to 
measure the Ca
2+
 concentration at different time points and replaced by fresh PBS. The Ca
2+
 
concentration was measured as followed: calcein solution (1mg/ml) was added and reacted with 
the Ca
2+
 released in the PBS to form a green-yellow color. Na2-EDTA solution was added to 
chelate with Ca
2+
 to form a green color. The microplate reader was used to measure the 
fluorescent intensity (FI sample) of the solution. At the same time, fluorescent intensity of blank 
group (FI blank) was measured as well. The Ca
2+
 concentration = ((FI sample-FI blank)/(-
5000))^1.5. The continuous degradation curve was plotted. 
2.3 Results 
2.3.1 Gradient and homogenous scaffolds structure by MicroCT scanning 
A three dimensional rendering of homogenous and gradient scaffolds is shown in 
Figure.3.The average pore size of the homogenous scaffold was 0.21mm. For the gradient 
scaffold the pore size decreased from first layer (0.38mm) to fourth layer (0.08mm). Also the 
porosity of the gradient scaffold was decreased from 65% (first layer) to 13% (fourth layer). And 
the porosity of homogenous scaffold was 32% (Table 1). The pore size distribution differed 
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among the layers of the gradient scaffold. In the first layer, a high percentage (63%) of the pores 
was greater than 300um in size. In the second layer, 72% of the pores fell within 75 – 250um in 
size. The pore size continued to decrease in the third layer, and by the fourth layer 68% of the 
pores fell below 75µm in size (Figure 4). The percentage of pores that were connected to the 
outside environment through 20µm openings was 100%, 93%, 76%, and 46% for layers 1, 2, 3, 
and 4 of the gradient scaffold. These percentages dropped to 89%, 15%, 11%, and 14% for 
200µm openings. As for the homogeneous scaffold, 79% of the pores were connected to the 
outside environment through 20µm openings and 10% for 200µm openings (Figure 5). 
2.3.2 SEM scanning of gradient and homogenous scaffold  
Both the gradient and homogenous scaffolds exhibited 3D interconnected pore structure 
(Figure 6). For the gradient scaffold, the majority pores on the top were open pore (connected 
pore), and most of the pores had larger inter space. The middle and bottom layers exhibited a 
denser structure; not only the pores became smaller, but also became isolated. Overall, the pore 
size and interconnectivity of gradient scaffold declined from the top to the bottom the 
interconnectivity of the structure declined. Meanwhile, for the homogenous scaffold, the pore 
size and interconnectivity of pores kept evenly distribution. 
2.3.3 Mechanical property 
Generally, the homogenous scaffold can endure higher mechanical stress (9.03MPa) than 
the gradient scaffold (6.12MPa) (Figure 7 -8). And the maximum strains of homogenous and 
gradient scaffolds were 0.024 % and 0.25% respectively (Figure 7-8). At the same time, the 
Young’s Modulus has been calculated based on the stress and strain curve. As the same, the 
Young’s Modulus of homogenous scaffolds (6MPa) was higher than the gradient scaffolds’ 
(3.5MPa) (Figure 9a). The stress distribution of homogenous scaffold uniform distributed 
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through out of the scaffold; while in gradient scaffold, the stress loading mainly focused on the 
middle and bottom of the scaffold which was the area with smaller pore size (Figure 9b). 
2.3.4 In vitro degradation study 
The degradation of gradient and homogenous scaffold exhibited similar pattern and speed. 
Both of them have high degradation speed at beginning and kept stable after sixteen days (Figure 
10) 
2.4 Discussion 
The novel gravity sintering method was easy to processing. After sintering, the solid and 
compressed amorphous CPP materials were recrystallized, forming a harder structure. Using the 
graded size of porogens was easy, controllable to form gradient pore size and different porosity. 
Our results showed that the gradient scaffold had three-dimensional interconnected pore 
structure. The four functional layers of the gradient scaffold were obviously (Figure 3). The 1
st
 t 
and 2
nd
 layers mainly distributed by open pores (>250µm), resulting in higher porosity (65%, 
55%) and interconnectivity. Thus, it could provide larger space for cell ingrowth and 
osteogenesis because osteogenesis prefer happening in the area with large pore size (>300µm). 
The wider connection space between pores provided a favorable matrix for cell migration and/or 
growth into the pores. While the 3
rd
 and 4
th
 layer exhibited dense structure with small pore size 
and porosity. This structure mimics the structure of nature bone. When the scaffold implanted 
into body, the layers with larger pore size and porosity enable the cell ingrowth, nutrition and 
oxygen transportation; meanwhile the dense layers can support sufficient mechanical strength.  
The mechanical strength is the other important factor for the bone graft. As mentioned 
above, the calcium polyphosphate can stand higher mechanical loading than some other 
materials like HA and TCP. In this study, the maximum mechanical strength of gradient and 
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homogenous scaffold was 6.5MPa and 9MPa respectively. The stress-strain relation of gradient 
scaffold was different from the homogenous one. Since the first and second layers of gradient 
scaffold has weak mechanical strength. As the results, the structure of these two layers damaged 
firstly, and then it with the 3
rd
 and 4
th
 layer stood the loading force together. In the Figure 8, the 
strain percentage did not decrease after compression, indicating that the structure of gradient 
scaffold was damaged to some extent. And the 3
rd
 and 4
th
 layers of the gradient scaffold bear the 
most mechanical strength (Figure 9b). In order to improve the mechanical strength, we may try 
to use much finer CPP powder (<38µm in diameter). Since densification rates are inversely 
proportional to powder size [50]. Pilliar et al. compared the mechanical strength of coarse 
powder sample (particle size: 150-250µm) with fine powder sample (106-150 µm)[39], and 
found the fine powder scaffold can bear four times higher loading force than the coarse powder 
scaffold. So finer powder scaffold can bear higher loading force.  
Biodegradation rate is crucial to bone graft because it can impact osteogenesis. The two 
type of scaffold exhibited similar degradation trend and speed (Figure 10). It means that the 
different structure of scaffold cannot change the degradation rate of the material. The 
degradation rate of CPP can be controlled by many factors. For example sintering procedure 
(time and temperature) enable to affect (PO4)
3-
 chain length which is related to the degradation 
rate. In addition, crystal structure, degradation medium and porosity can change the degradation 
rate. 
In general, the novel gravity sintering approach had successfully established gradient 
CPP scaffold. The gradient scaffold has clearly four functional layers with gradient pore size. 
The reduction of mechanical strength of gradient scaffold can be improved by using finer powder. 
Besides, the biodegradation rate was controllable. Thus, the gradient scaffold with its unique 
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structure has many advantages than the homogenous scaffold. Then we compared the cell 
behaviors cultured on the gradient and homogenous scaffold. 
 
 
Layers 
Materials 
ACPP powders (g) Stearic Acid (g) Stearic Acid size (x, 
µm) 
1
st
  layer 0.225 0.15 x>300 
2
nd
 layer 0.225 0.15 250<x<300 
3
rd
 layer 0.225 0.15 75<x<250 
4
th
 layer 0.225 0.15 x<75 
Sample Porosity 
(%) 
Tb. Th 
(mm) 
Tb. Sp 
(mm) 
Gradient Layer 1 65% 0.21 0.38 
Gradient Layer 2 55% 0.10 0.13 
Gradient Layer 3 32% 0.11 0.10 
Gradient Layer 4 13% 0.13 0.08 
Homogeneous 32% 0.12 0.21 
Table 1 Materials component for gradient scaffold 
Table 2 Scaffold morphology 
Figure 1 Projection of the CPP structure along x. Dashed lines is 
(Ca(1)-Ox)-polyhedra; Continuous lines is (Ca(2) – Ox)-polyhedra 
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Figure 2  The fabrication process of gradient and homogenous scaffolds 
Figture 3 3D rendering homogenous (A) and gradient (B) scaffold showing the 
different layers within the gradient scaffold (C).Layer 1: >300μm; Layer 2: 250-300μm; 
Layer 3: 75-250μm and Layer 4: <75μm. 
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Figure 4. Distribution of pore size 
 
Figure 5 Interconnectivity 
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Figure 6 The SEM image of gradient and homogenous scaffold 
Figure 7 The stress and strain curve of homogenous scaffold 
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Figure 8 The stress and strain curve of gradient scaffold 
Figure 9 (a) The Young’s Modulus of gradient and homogenous scaffold. (b) The distribution of 
stress of gradient and homogenous scaffold 
23 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 Bioreactor design and condition setting  
3.1 Introduction 
The bioreactor is a device which use mechanism method to control and effect biological 
process. Compared to static cell culture, the dynamic cell culture has many advantages. Firstly, 
the dynamic cell culture maintains and provides ideal concentration of nutrition and oxygen 
through out of the scaffold [51]. It is important to the 3D scaffold because the static cell culture 
cannot provide enough nutrition and oxygen to the cells grown in deeper region of the 3D 
scaffold. Secondly, the bioreactor can enhance cellular spatial distribution [51]. Thirdly, the 
bioreactor provides physical stimuli. Bone cells are more sensitive to mechanical stimuli than 
other cells. Since muscle contraction, body movement and fluid flow can cause hydrostatic 
pressure, cell strain and shear stress. These mechanical stimuli stimulate cell proliferation, 
differentiation and increasing bone mass [52]. The bioreactor can provide shear stress through 
Figure 10 The degradation of gradient and homogenous 
scaffold 
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flowed culture medium. In conclusion, the dynamic cell culture by bioreactor, better mimicked 
the physiological environment, is a desired approach for cell culture in tissue engineering. 
The basic bioreactor should have cell culture chambers, medium reservoir, gas exchange 
device and power system. The cell culture condition can be controlled such as temperature, 
humidity, oxygen and carbon dioxide concentration and medium pH value [53]. Additionally, 
materials used for bioreactor should be biologically inert and noncorrosive at least. Furthermore, 
the physical stimuli should be controlled by flow rate or rotate rate [53]. The shear stress in 
bioreactor is related to flow rate, pore size, porosity and viscosity of the medium. For this reason, 
a desired shear stress should be calculated for different scaffold. 
There are many types of bioreactor such as spinner flask bioreactor, rotating bioreactor 
system and perfusion bioreactor system. The main limitation of the spinner flask bioreactor and 
the rotating bioreactor is unevenly nutrition and shear stress distribution [54]. The perfusion 
bioreactor can provide more homogeneous nutrition and shear stress throughout scaffolds. Since 
the mechanism of the perfusion flow bioreactor is usage of a pump to force media flow through 
the scaffold. So it was widely used in bone tissue engineering. For example, Glowachi, et al 
seeded bone marrow stromal cells on collagen spongy scaffold and cultured by perfusion 
bioreactor. The results showed cells distributed on the scaffold evenly, and proliferation was 
better in comparison to static culture [55]. Therefore after comparison, in this study, we chose 
the direct perfusion flow bioreactor as the cell culture method. 
3.2 Materials and Method 
3.2.1 Materials 
MT3T3-E1 cell line was obtained from American Type Culture Collection (ATCC) 
(Manassas, VA).  α-Modified minimum essential medium (α-MEM) and Fetal bovine serum 
were purchased from Invitrogen (Carlsbad, CA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-
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diphenyltetrazolium bromide (MTT) assay kits was from ATCC (Manassas, VA).  Pyrex round 
medium storage bottle, 15ml centrifuge tubes and 10ml syringe were from Sigma-Aldrich (USA). 
Silicon glue and epoxy purchased from Loctite (USA). Cell culture incubator was purchased 
from Queue Incubator (Paris, France).Silicon tubes and parts were from Nalgene and Cole-
Parmer. Low oxygen gas mixture (5% oxygen, 10%carbon dioxide, balance nitrogen) was from 
Metro Welding (Detroit, MI). Microplate reader was obtained from BioTek (USA). Confocal 
Microscopy was from Leica TCS SP5 (USA). 
3.2.2 Customized bioreactor preparation 
3.2.2.1 Perfusion flow bioreactor design 
We designed consisted of four parallel, vertically oriented cylindrical chambers, a cell 
culture medium reservoir, a peristaltic pump and a gas exchanger. The cell culture chamber 
consisted of autoclavable polypropylene plastics which were made by 15ml centrifuge tube and 
10ml syringe. And a nylon cloth was placed at the middle of the chamber for supporting the 
scaffold. The gas exchanger was constructed by gas permeable silicone tube with five loops in 
the atmosphere with 5% of CO2.  After flowing out of the gas exchanger, the cell culture medium 
went through the chambers from top to bottom and recirculated through the chambers by 
peristaltic pump. The volume of culture medium used for the bioreactor system was 30ml.  
3.2.2.2 Sealing method and toxicity test 
Silicon glue and epoxy were chosen as glue to seal the chambers’ wall and caps. Before 
use the cell toxicity of these materials was measured by MTT method. Briefly, there were three 
treatments: (1) MC3T3-E1 cells + dried silicon glue; (2) MC3T3-E1 cells + epoxy; (3) control 
(MC3T3-E1 cells only). Firstly, same volume of silicon glue and epoxy were coated on 24 wells 
plate and tried overnight. Secondly, after sterilized the plate by UV light, 2.6*10
3
 MT3T3-E1 
cells were seeded in each well and cultured for 7 days. Thirdly, 20µl MTT reagent was added 
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into each well and incubated for 2 to 4 h until the blue crystal formazan formed. 250 µl DMSO 
was added as followed to dissolve the crystal formazan. Finally, the microplate reader was used 
to measure the color at 560nm which reflected the cell proliferation. All treatments were 
performed in duplicated. 
3.2.2.3 Leakage test, gas exchange system test and contamination test 
Assembled bioreactor was sterilized by autoclave. And the whole bioreactor filled with 
30ml culture medium was stabilized by a cleaned retort stand in the cell culture incubator. Also a 
part of silicon tubes were connected with peristaltic pump as power to circulate the medium. The 
gas exchange tubes were put inside a small plastic bag (5cm x 5cm) with gas supplied. After 
installation, the entire bioreactor system ran for a week in order to test leakage, contamination 
and function of gas exchanger. 
3.2.3 Perfusion condition 
3.2.3.1 Gravity flow rate test 
The gradient and homogenous scaffolds were installed and tightly sealed on the bottom 
of cut 15ml centrifuge tubes (Figure 11). In order to test the gravity flow rate of each scaffold, 
10.5 ml distilled water was added into each tube. Thus the gravity flow rate (ml/min) equaled to 
the volume of distilled water divided by consuming time. 
3.2.3.2 Theoretical calculation  
The bioreactor system was used directly perfusion bioreactor.  The Hagen-Poiseuille 
relation ( =8 µν/ds) for laminar flow through a round conduit was applied [56]. The calculation 
details were list as below: 
(a) =8 µν/ds (physiology shear stress : 0.8Pa-3.8Pa [57]; viscosity of cell culture medium 
µ: 0.77x10
-3 
Pas; the average diameter of pore ds: 0.21mm);  
Flow rate (v): 27mm/s-129mm/s;  
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The average flow rate (v’): 78mm/s 
(b) Area per pore: A= x r2=3.46x10-4 cm2    
(c) The volume of fluid per pore: V=v’ x A=2.7x10-3cm3/s  
(d) The cross section area of scaffold: Ac=0.78cm2 
(e) The total pore area: At=0.78x0.32(porosity)=0.25cm2 
(f) The number of pore: N=At/A=726 
(g) The total volume of fluids/s: Vt=N x V=1.96ml/s 
After cell seeding, the pore size would be narrowed. Therefore, the final flow rate should be 
lower than the calculated result. 
The optimal amount of seeded cells is another parameter to optimize for cell culture. 
Generally, the total volume of seeded cell should take 20% empty space of scaffold. Based on 
that, the optimal amount of cells that should be seeded can be calculated. The processing was 
listed as followed: 
(a) The total volume of the pore: gradient scaffold equaled to 0.225 cm3; 
homogenous scaffold equals to 0.17472 cm
3
.  
(b) The average volume of pore: 0.19986 cm3 
(c) The volume of per cells: around 6.5*104µm3 
(d) The optimal amount of seeded cell: around 5.8 *105 cells 
3.2.4 Cell seeding condition 
3.2.4.1 Oscillating cell seeding 
According to many researches, the oscillating cell seeding method results in high seeding 
efficiency and even cell spatial distribution [58, 59]. Therefore, we used the oscillating cell 
seeding method. Firstly, sterilized scaffold and bioreactor system, as well as 10ml cell 
suspension (7*10
5
 cells / ml) were prepared. Secondly, in order to force the flow throughout of 
28 
 
 
 
the scaffold directly, the gradient and homogenous scaffolds were tightly confined in bioreactor 
chambers. Thirdly, culture medium was pumped (1ml/s) from top to bottom of the scaffolds for 
18 seconds, and then changed the flow direction. Thus, each oscillating cycle lasted 36 seconds. 
The cycles were repeated 100 times and 200 times respectively. Finally, after cell seeding, the 
scaffolds were incubated for 2 hours. As the same, the amount of cells was tested by MTT 
method. 
3.2.4.3 Manual cell seeding 
Cell suspension with density (2*10
6
 cells / ml) was manually pipetted to the top, bottom 
and side of each sterilized scaffold with 10µl droplet. Each scaffold was loaded the 300 µl cell 
suspension. After that, the cell seeded scaffolds were incubated for 2 hours. Also, test the cells’ 
amount by MTT method and observe the cell’s distribution by confocal microscopy. 
3.2.5 Statistic Analysis 
The software of SPSS will be used in the statistical analysis. The experiment results were 
calculated mean and standard deviation. Two tail student t test was used to analyze the results. 
The statistical significance (p) is 0.05. 
3.3 Results 
3.3.1 Customized perfusion flow bioreactor 
The schematic diagram of perfusion flow bioreactor was showed in Figure 14A. And the 
entire bioreactor system was exhibited in Figure 14B.  The four parallel chambers, medium 
reservoir and gas exchanger were put in the incubator. Through pressing silicon tubing by 
peristaltic pump, culture medium enabled to pump to the chambers from top to bottom. The 
chamber design was shown in Figure 12. It is composed of half 15ml centrifuge tube and half 
10ml syringe. In the middle of the chamber, a nylon cloth was settled as a scaffold holder (Figure 
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12c). The scaffold was tightly connected with the chamber through an O-ring. The cap of 
chamber was drilled in the center and linked with a connecter (Figure 12b).  
In the toxicity test, the cell proliferation of three treatments has no significant difference. 
Thus, the silicon glue and epoxy were nontoxic to cells (Figure 15). Moreover, after testing, we 
found only the epoxy could seal the chamber wall and cap firmly. The bioreactor system worked 
well. Through out of the experiment, no liquid leakage and contaminations were observed. The 
gas exchanger system was functional because the color of cell culture medium changed to dark 
orange after thirty minutes of culture.  
3.3.2 Perfusion condition 
In the gravity flow rate test, the gravity flow rate of homogenous scaffold was 3.425 
ml/min, and the gradient scaffold was 4ml/min. Sine after cell seeding, the pore size would be 
narrowed. Also based on the gravity flow rate, the flow rate was set as 1ml/s. And the optimal 
cells’ amount was 5.8*105 cells. 
3.3.3 Cell seeding  
Compare seeding efficiency by two approaches, the amount of cells seeded on gradient 
scaffold by manually seeding were significantly higher than through oscillating cell seeding (100 
cycles, p=0.005) (Figure 17). As the same, for homogenous scaffold, the efficiency of manually 
seeding was higher than oscillating seeding significantly (100 cycles, p=0.013). Increasing the 
cycle times did not improve the seeding efficiency, adversely, the efficiency decreased 
dramatically (Figure 17). While seeding method did not impact the seeding efficiency on 
different scaffold, for each method, the seeded cells’ amount was similar on gradient and 
homogenous scaffold and no significant difference (p>0.05) (Figure 17). 
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Cell distribution after manually seeding was exhibited in Figure 18-19. In gradient 
scaffold, the cell exhibited grade distribution. Most of cells attached to the top layer, larger pore 
size and porosity, of the scaffold; seldom cells attached to the middle-bottom layers (Figure 18). 
In homogenous scaffold, cell distribution on each layer was relatively even (Figure 19).  
3.4 Discussion 
In order to provide similar physiological environment for cell growth, the perfusion 
bioreactor system was applied in this study. The perfusion bioreactor was successfully designed 
and able to provide dynamic culture. Its independent four chambers allowed for easy analysis 
each scaffold as one scaffold moved out cannot affect others. And the bioreactor system is easy 
to add several parallel chambers depending on experiment requirement. Besides, the assembled 
whole system is autoclavable together. This efficient sterilization reduces the risk of bacterial 
contamination. The sealing and leakage problems were crucial to this bioreactor. Silicon glue 
was first considered because it is non-toxic and waterproof. However, the silicon glue failed to 
seal the chamber’s wall and cap because it is not suitable for sealing polypropylene plastics. As a 
result, the epoxy was chosen. Fortunately, it was non-toxic and functional. Also some parts of 
the bioreactor, likes tube and chamber, should be replaced after several times autoclave and cell 
culture, because plastic would be aging and degrade. Thus, choosing long lasting material for 
bioreactor is important such as glassware. Overall, the self-designed perfusion flow bioreactor 
system was effective, cheap and easy to fabricate. 
 Perfusion conditions likes flow rate and shear stress can decide cells’ behavior. The flow 
rate is a significant parameter for cell culture, decides shear stress on cells and affects nutrition, 
oxygen and wastes transport. In this study, the flow rate was 1ml/s which can be accurate 
controlled by peristaltic pump. Also entire silicon tubes kept same inner diameter that means the 
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flow rate was constant through out of the bioreactor. The Hagen-Poiseuille relation for laminar 
flow through a round conduit was applied to calculate the flow rate. At the same time the 
Reynolds number (Re=ρvL/µ, ρ is the density of the fluid, v is the mean velocity of the fluid, L 
is travelled length of the fluid, µ is the dynamic viscosity of the fluid) was prerequisite for using 
Hagen-Poiseuille to identify the laminar flow. After calculation, the Re was less than 1 which 
meant it could be considered as laminar flow through a round conduit. Thus although the Hagen-
Poiseuille relation is not accurate enough, it is suitable for this study. Besides, the shear stress 
formed by 1ml/s flow rate was close to 2 Pa which was in the physiology range. 
Cell seeding is important for this study. The amount of seeded cells and cellular 
distribution were two important factors. The optimal seeded cells’ volume should take 20% of 
the volume of total pores. Based on this principle, the total pores’ volume of gradient and 
homogenous scaffolds were 0.225 cm
3 and 0.17472 cm3 respectively, and there was no 
significant difference between two scaffolds. Therefore, the average pores’ volume was used to 
calculate the amount of cells which is 5.8*10
5
 per scaffold. A good seeding method should keep 
the cell’s amount and distribution evenly on each scaffold.  Oscillating perfusion seeding 
resulted in a high seeding efficiency (70%-90%), and it distributed cells evenly throughout the 
scaffold [60, 61]. For this reason, static (manual) and oscillating perfusion seeding methods were 
tried in the study. However, the results were inversely. Not only the amount of seeded cells by 
oscillating seeding were significant less than the static (manual) seeding, but also the seeding 
efficiency of oscillating seeding (100 cycles, <10%) was much lower than the manual seeding 
(20%). It may because of the high flow rate for cell seeding. Since cells do not have enough time 
to attach to the scaffold if the flow rate is high[61], and most of the cells may finally deposit to 
the bottom of the bioreactor by the effect of gravity. In addition, increasing the cycle time did not 
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improve the seeding efficiency. Some previous research found that the high cycle number could 
improve cell distribution throughout of the scaffold, but also had negative effect on cell viability 
[62]. Besides, we designed bioreactor may not be an ideal equipment for oscillating seeding. The 
scaffold is better to keep inside a relative small cassette. Also cell suspension for seeding prefers 
to have small volume and high cell density. Since these setting can make sure that the majorities 
of cells pass through scaffold and reduce cells attaching the tubes of bioreactor. The other 
limitation of cell seeding study was that the MTT method was not the optimal method to test 
cells’ quantity on this 3D thick, porous scaffold, because not all of formazon can be completely 
washed out. Therefore, the actual seeding efficiency of these methods may be higher than the 
results. Furthermore, for the gradient scaffold, oscillating perfusion seeding may not be suitable. 
Since after constant perfusion, the grade porous structure could cause most of cells deposit at the 
border of layer with large pore size and layer with small pore size. There are currently fewer 
studies being performed to investigate the effects of dynamic cell seeding onto gradient scaffolds. 
Therefore, in order to improve seeding efficiency, gradient scaffold cell seeding needs further 
study. 
After manual seeding, cell distribution also observed by confocal microscopy. Each 
scaffold was manually divided into three layers: top (porous structure), middle, and bottom 
(dense structure) to observe cell distribution on each layer. On one hand, in gradient scaffold, the 
major cells were deposited on the top layer and the number of cells dropped from top to bottom. 
This proved our hypothesis that was porous layer can provided large space for cell growth. On 
the other hand, cells distributed evenly throughout of the homogenous scaffold. In conclusion, 
according to the results of MTT and confocal microscopy, we thought the manual seeding 
approach provided better cell growth. Besides since the seeding efficiency was low, we enhanced 
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the cell seeding density to 3*10
6
/ml for the next experiment. In the next part, we would compare 
the cell behavior on two kinds of scaffolds after dynamic cell culture. 
 
Figure 11 The gravity flow rate test. The scaffold was tightly sealed with the tube by silicon glue. 
Figure 12 The chamber design. (a) The body of chamber was consisted by half 
centrifuge tube and half syringe. Epoxy was used to seal these two parts. (b) Gap 
design.  (c) a nylon cloth was put in the middle of the chamber as scaffold 
holder. 
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Figure 13 Medium reservoir 
design.  
A 
B 
Figure 14  (A) The schematic diagram of bioreactor. (B) The perfusion flow bioreactor. 
35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
0.5
1
1.5
2
2.5
1
O
D
 V
al
u
e
 
Treatments 
silicone glue
epoxy
control
Figure 15  Toxicity test for silicone glue and epoxy 
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Chapter 4 In vitro comparison/evaluation of osteoblastic cell behavior between two 
scaffolds 
4.1 Introduction 
MC3T3-E1cell line, murine preosteoblasts, originates from C57BL/6 mouse calvaria and 
selected on the basis of high alkaline phosphatase activity. It is able to differentiate to osteoblasts 
and osteocytes and to form mineral deposit, hydroxyapatite. After studying the physiochemical 
characterization of scaffolds as well as the setting of perfusion flow cell culture, we used 
MC3T3-E1 cells to compare cell behavior, proliferation, distribution and differentiation, on 
gradient and homogenous scaffolds. We thought the gradient scaffold could improve the level of 
cell proliferation and differentiation, and affect the cell distribution. 
Figure 17  Cell distribution on gradient scaffold after manually seeding 
Figure 18  Cell distribution on homogenous scaffold after manually seeding 
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4.2 Materials and Methods 
MT3T3-E1 cell line was obtained from American Type Culture Collection (ATCC) 
(Manassas, VA).  α-Modified minimum essential medium (α-MEM) and Fetal bovine serum 
were purchased from Invitrogen (Carlsbad, CA). 3-(4,5-Dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) assay kits was from ATCC (Manassas, VA). Alkaline 
phosphatase (AKP) assay kit was from BioVision (San Francisco, CA). Cell culture incubator 
was purchased from Queue Incubator (Paris, France). Microplate reader was obtained from 
BioTek (USA). Confocal Microscopy was from Leica TCS SP5 (USA). 
4.2.1 Cell seeding and culture 
MC3T3-E1 Cell (p-13) suspension with density (3*10
6
 cells / ml) was manually pipetted 
to the top, bottom and side of each sterilized scaffold with 10µl droplet. Each scaffold was 
loaded the 300 µl cell suspension. After that, the cell seeded scaffolds were incubated overnight. 
The scaffolds were transformed to the perfusion bioreactor system. The cell culture condition 
was 37  with 5% of   2 and the culture medium was changed every two days. 
4.2.2 Cell Proliferation 
The cell proliferation was measured by MTT method. Briefly, after four days cell culture 
by the bioreactor, the cell growth scaffolds were placed in 24 well plates with 1ml culture 
medium. 20µl MTT reagent was added into each well and incubated for 2 to 4 h until the blue 
crystal formazan formed. 250 µl DMSO was added as followed to dissolve the crystal formazan. 
The microplate reader was used to measure the color at 560nm which reflected the cell 
proliferation. The MTT method was also applied after cell seeding. All measurements were 
performed in duplicate. 
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4.2.3 Cellular distribution 
To observe the cell distribution on the scaffold, confocal microscopy was applied. After 
four days cell culture, cells grown in the scaffolds were washed by PB  for 3 times and labeled 
with the 250 µl  il dye followed by incubating 15min at 37 . After washing with PBS for 3 
times, the scaffolds were measured by Leica TCS SP5 confocal microscopy to observe the cell 
distribution. 
4.2.4 Cellular Differentiation 
4.2.4.1 Pretest of cellular differentiation 
In order to obtain a desire differentiation results, we designed pretest to investigate a 
better method to digest cells. After fourteen days static cell culture by differentiated medium, the 
washed samples were divided into two groups: (1) scaffolds were crushed by liquid nitrogen and 
then added 250µl AKP buffer to lysate cells overnight at 4 ; (2) scaffolds were added 250 µl 
AKP buffer directly overnight at 4 . AKP activity in cell lysate was measured utilizing the 
conversion of a colorless p-nitrophenyl phosphate to a colored p-nitrophenol. The color change 
was measured microplate reader at 405 nm. AKP levels were converted from OD value to 
protein concentration based on standard curve.  All measurements were performed in duplicate. 
4.2.4.2 Cellular differentiation 
The cell differentiation was tested by alkaline phosphatase kit (AKP). After cell seeding, 
the scaffolds were placed inside the bioreactor chambers. Cells were cultured by differentiated 
medium for fourteen days. AKP test was followed. Firstly, the scaffolds were washed by PBS for 
3 times followed by centrifuge with 1000rpm for 2 min.  econdly, the scaffolds were crushed by 
li uid nitrogen, and then 250 µl A P buffer was used to lysate the cells overnight at 4 . Thirdly, 
AKP activity in cell lysate was measured utilizing the conversion of a colorless p-nitrophenyl 
phosphate to a colored p-nitrophenol. The color change was measured microplate reader at 
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405 nm. AKP levels were converted from OD value to protein concentration based on standard 
curve. All measurements were performed in duplicate.  
4.2.5 Statistic Analysis 
The software of SPSS was used in the statistical analysis. The experiment results were 
calculated mean and standard deviation. Two tail student t test was used to analyze the results. 
The statistical significance (p) is 0.05. 
4.3 Results 
4.3.1 MTT test results 
After cell seeding, the amount of cells on the each scaffold was no significant difference, 
and the OD value was around 0.1(Figure 19).  The cell proliferation shows no obviously 
difference no matter by static or dynamic cell culture as well (Figure 20-21). However, the cell 
proliferation by dynamic culture was two times higher than the cell proliferation by the static cell 
culture. 
4.3.2 The cellular distribution images by confocal microscopy 
The confocal microscopy images showed the 3D cells distribution on the scaffold. The 
dyed cells exhibited red dot. And the distance of unit square was around 155µm. Although the 
amount of grew cells were similar in the same area, the cells on the gradient scaffold (Figure 22a) 
grew deeper (311.8 µm) than the cell grew on the homogenous scaffold (115.9 µm) (Figure 22b). 
4.3.3 The cell differentiation results by AKP test 
In the pretest, although no significant difference between the two groups, the group one 
(crushed scaffold) had higher AKP level than the group two for both homogenous and gradient 
scaffolds. After dynamic culture for fourteen days, the MT3T3-E1 cells have differentiated. For 
the gradient scaffold, the level of cells’ A P activity (concentration) was over 1.23, which was 
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more than 2 times higher than the cells grown on the homogenous scaffold (Figure 24). Based on 
statistical analysis, the difference was significant (P<0.01). 
4.4 Discussion 
We studied cells behavior between two scaffolds after dynamic culture. Each scaffold 
had been seeded on same amount of cells. After cell culture for four days, the cells’ proliferation 
has no significant difference between two kinds of scaffolds for both dynamic and static culture. 
According to that the graded pore structure seems do not affect the cell proliferation. The reason 
for that may be the total pore volume, the space for cells growth, in two kinds of the scaffolds 
was similar. However, when comparing the dynamic and static culture, it showed that cell 
proliferation by dynamic culture was two times higher than the static cell culture. It proved that 
the perfusion condition was suitable for MT3T3-E1 cells growth. Moreover, the bioreactor was 
direct medium perfusion which uses an O-ring to tightly seal the space between chamber wall 
and scaffold. It forces the medium flow through the scaffold and the shear stress directly 
transferred to the cells. Consequently, it succeeded to transport enough nutrition and oxygen 
through out of the scaffold and improved the efficiency of cell culture. The graded pore structure 
impaired the cell distribution. From the confocal microscopy image, the cells can grow deeper in 
the gradient scaffold as the 1
st
 and 2
nd
 layers have larger pore size and interconnectivity. This 
realized our design and proved our hypothesis which was the 1
st
 and 2
nd
 layers of the gradient 
scaffold should be responsible for cell growth. 
The graded pore structure also impacted the cell differentiation. The level of AKP 
activity from gradient scaffold was more than two times higher than the homogenous scaffold. 
Thus the gradient structure did benefit to the cell differentiation. We supposed that the difference 
was original from the different structure of 1
st
 and 2
nd
 layers of the gradient scaffold.  Since these 
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two layers have comparative larger pore size, higher porosity and interconnection than the 
homogenous one which benefit nutrition an oxygen transportation.  As the results, cell can grow 
and develop better on 1
st
 and 2
nd
 layers of the gradient scaffold. Besides, the shear stress can 
impact cell differentiation. The shear stress on the 1
st
 layer of gradient scaffold was 1.26 Pa 
which was lower than the shear stress on the homogenous one, 2.28 Pa. And both of the shear 
stresses were distributed in normal physiology range. However, it cannot prove our hypothesis 
only based on the A P test, since it was not directly exhibited differentiated cells’ location on 
the scaffolds. In conclusion, the gradient structure did impact the cellular distribution and 
enhanced the cellular differentiation level. 
4.5 Limitation 
Since the scaffolds we studied was a firm and thick, nontransparent structure. The 
traditional experimental approaches were not suitable for testing. For example, in MTT test, the 
formazon cannot completely washed out from the scaffolds; and in AKP test, although the 
scaffolds had been crushed by liquid nitrogen, it still failed to confirm that all cells was digested 
and cannot show the distribution of differentiated cells; also, the deepest observing distant of 
confocal microscopy was around 500 µm, but the scaffold had 0.8 cm in height and 1cm in width. 
Thus the image of confocal microscopy failed to reflex the real cell distribution. For these 
reasons, we applied a new labeling combined with micro-PET scanning to overcome the 
drawbacks.  
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Figure 22 The cell distribution on the gradient (a) and homogenous (b) scaffold.  
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Chapter 5 Molecular PET imaging to monitor cells growing in 3D scaffolds  
5.1 Introduction  
Positron emission tomography (PET) uses nuclear medical imaging technique which can 
detect the pairs of gamma rays emitted by a positron-emitting radionuclide, tracer, to produce a 
three-dimesional image or picture or functional processes in the body. PET can be used in both 
medical and research. In clinical, it is widely applied in oncology for diagnosis tumor. In 
research, PET can be used for small animal imaging which called micro-PET. 
18
F-fluoride (
18
F-), is a nonspecific bone tracer that has been used for skeletal imaging 
since the late 1960's [63]. It can diffuse through capillaries into bone extracellular fluid and 
exchange of fluoride ions with hydroxyapatite crystals forming fluoroapatite slowly. 
18
F-PET is a 
useful tool to detect and analysis new bone forming and the healing of morselized bone allografts. 
Uilmark et al. used 
18
F- PET to monitor new bone formation in periacetabular bone adjacent to 
the implant in 16 bilateral THA patients 1 week, 4 months and 12 months after surgery and 
conclude that 
18
F- PET was an efficient tool to analysis the new bone forming [64]. In addition, 
18
F- PET usually combines with CT to detect osteoblastic lesions. 
     Tetracycline (TC) has high binding affinity to hydroxyapatite (HA, Ca5(PO4)3(OH)) 
through the oxygen ion on C10,C12 and C2 of TC chelate three calcium ions on HA(Figure 26) .  
Additionally, the calcium polyphosphate ([Ca2(PO3) 4]x  is hard to bind with TC because it has 
low Ca/P ratio and high steric effect based on the crystal structure (Figure 1). Therefore, TC 
labeling has been widely used to study bone turnover and new bone formation under normal and 
disease conditions[65]. When TC absorbed, it is primarily incorporate into the mineralization 
front of the new bone and can be detected by its fluorescence [66]. Kovar et al. recently reported 
near-infrared (NIR) labeled TC derivatives to be effective as markers of the bone mineralization 
process[67].  
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In this study, 
18
F-fluoride PET technology was applied to investigate osteoblast cells’ 
behavior and new bone forming on gradient and homogenous scaffolds. Since the 
18
F-fluoride 
PET can observe and produce a 3D image based on the signal from entire scaffold. Therefore, it 
can overcome the limitations as mentioned above. Also fluorescent tetracycline labeling was 
used to detect the new forming hydroxyapatite which was able to forward reflect the 
differentiated level of cells and new bone forming. We hypothesized that the level of cells’ 
differentiation and new bone forming on gradient scaffold could be higher than homogenous 
scaffold. Also the new formed HA may mainly deposited on the 1
st
 and 2
nd
 layer of gradient 
scaffold. 
5.2 Materials and Method 
5.2.1 Materials 
MicroPET Rodent R4 was from Concorde Microsystems Inc.(USA), 
18
F-fluorine solution 
was obtained from PET center  F  hildren’s Hospital of Michigan, fluorescent tetracycline was 
from Sigma-Aldrich (USA), fluorescent microscopy (AxioCam MRc) was from Zeiss. 
5.2.2 Preliminary study (wash method) 
In order to find an optimal washing method, three washing conditions were designed: (1) 
washing scaffold three times with 150rmp (5min per time); (2) washing scaffolds five times with 
150 rmp (2 min per time); (3) washing scaffolds ten times with 150 rmp ( 2 min per time). After 
soaking in FDG solution for 15min, the gradient and homogenous scaffold were washed by three 
different conditions, and then the scaffolds in each group were scanned by molecular PET. 
5.2.3 
18
F-fluorine PET scanning 
After culture 14 days with differentiation medium, the gradient and homogenous 
scaffolds were soaked in 18F-Floride medium with 150 uCi and incubated for 15 min in 
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incubator. After labeling, each scaffold was washed by PBS for three times. And PET scanning 
was used to detect the signal for 30 min. 
5.2.4 Tetracycline labeling  
Fluorescent labeled tetracycline is able to specific bind with the new forming 
hydroxyapatite (HA, Ca5(PO4)3(OH)).The remained grounded material from AKP test was used 
for tetracycline labeling. All samples were stored in 1.5ml eppendorf tubes separately 
and avoided light for 10mins followed by washing 3times with distilled water. Finally, the 
material in each group was placed on glass slides and observed via fluorescence microscopy with 
FITH filter.  
5.2.5 Statistical analysis 
 
The software of SPSS was used in the statistical analysis. The experiment results were 
calculated mean and standard deviation. Two tail student t test was used to analyze the results. 
The statistical significance (p) is 0.05. 
5.3. Results 
5.3.1 Preliminary study 
The three wash methods were efficient for both gradient and homogenous scaffolds. 
Seldom signal was detected. The first washing condition was chosen. 
5.3.2 PET scanning image 
The intensity of radioactivity of the scaffold was exhibited in Figure 27. The signal 
intensity reflected the amount of new forming HA. For the gradient scaffold (Figure 26a), the 
intensity of radioactivity of each layer was 3.64 + 1.50 uCi (1
st
 layer), 4.07 + 0.98 uCi (2
nd
 layer), 
3.49 + 1.31 uCi (3
rd
 layer) and 3.12 + 1.51 uCi (4
th
 layer). And for the homogenous scaffold 
(Figure 26b), the intensity of each layer was: 3.29 + 1.13 uCi(1st layer),  2.66 + 1.51 uCi (2nd 
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layer), 2.23 + 0.95 uCi(3rd layer), 2.23 + 0.95 uCi (4th layer). The radioactivity of the top two 
layers (1
st
 and 2
nd
 ) of the gradient scaffold was significantly intense than the radioactivity of 
homogenous scaffold (P<0.05). Also Figure 28 was a coronal image in which Figure 28a showed 
the radioactive intensity of gradient scaffold, and Figure 28b represented the homogenous 
scaffold. 
5.3.3 Tetracycline labeling 
Fluorescent tetracycline can only label new forming hydroxyapatite. The grounded 
scaffold without cells growth which was incubated in bioreactor for fourteen days as well cannot 
be label by fluorescent tetracycline (Figure 29a). Also for the homogenous scaffold with cell 
growth, the fluorescent signal was not obvious (Figure 29b). However, after fourteen days cell 
culture, the grounded gradient scaffold can be labeled by tetracycline (Figure 30). And clear 
crystal structure of hydroxyapatite was observed under the fluorescent microscopy (Figure 30b). 
5.4 Discussion 
In this chapter, we used 
18
F-Fluoride PET to obtain the figure of HA distribution on the 
entire scaffolds. Delimiting background noise was the first step to make sure a good result of 
micro-PET scanning. We found that a gentle speed with rapid changing washing medium can 
reach an efficient washing result without affecting cells for the thick, porous structure. And 
finally 1
st
 washing condition was chosen which was efficient and convenient.  
The MT3T3-E1 cell line enable to differentiated into osteoblast cell and osteocytes which 
can form osteoid matric including hydroxyapatites (HA), calcium carbonate and calcium 
phosphate [2,8]. Therefore, the level of HA reflects the level of cellular differentiation. The 
results of micro-PET scanning showed that the HA deposition on gradient scaffold was 
significant higher than it on the homogenous scaffold which conformed to the AKP test.  The 
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more important was that the image proved that HA was mainly deposited on the 1
st
 and 2
nd
 layer 
of gradient scaffold. Since the osteogenesis occurs at the area with large pore size (>350µm), 
high porosity and high interconnection in vivo [32]. Thus, the 1
st
 and 2
nd
 layers of gradient 
scaffold are suitable for cellular differentiation. In addition, the osteoblast and osteocytes are 
very sensitive to mechanical strength which induces them secreting many growth factors and 
promote the formation of osteoid matrix [2]. As the result, different shear stresses caused by 
different micro-structure of the scaffolds also impact the cellular differentiation and osteoid 
matrix formation.  Therefore, the gradient scaffold with different functional layers was benefit to 
the cell differentiation and the formation of osteoid matrix. Not only did the level of 
differentiation on the 1
st
 and 2
nd
 layer on gradient scaffold was higher than its 3
rd
 and 4
th
 layer, 
but also the level of differentiation of entire gradient scaffold was higher than homogenous 
scaffold. 
Mature osteoblast cells can secrete hydroxyapatite which is the majority inorganic 
component in extracellular environment of bone tissue. The fluorescent labeled tetracycline can 
only chelate to new forming hydroxyapatite rather than the CPP molecular because of the 
difference of Ca/P ratio and steric effect of these two molecular.  Only in gradient scaffold, a 
number of new forming hydroxyapatite crystals in tetragonum had been observed.  We did 
observed few new forming hydroxyapatites in homogenous, but they were not fully formed in 
tetragonum. These results directly exhibited the crystal structure of new forming HA, and proved 
the results of 
18
F-Fluoride micro-PET. 
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Figure 27 The intensity of radioactivity. (a) gradient scaffold (b) homogenous scaffold 
Figure 28 Coronal image of gradient (a) and homogenous (b) scaffold.  
Figure 26 The chemical structure of tetracycline molecule with areas of potential calcium chelation in boxes. 
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Figure 29 Fluorescent tetracycline labeling. (a) scaffold without cells (b) homogenous 
scaffold with cells growth 
Figure 30  Fluorescent tetracycline labeling for the gradient scaffold. (a) labeled hydroxyapatite 
crystal on gradient scaffold (10X) (b) A single hydroxyapatite crystal (40X) 
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Chapter 6 Conclusions 
The artificial bone grafts have been successfully applied to fix bone defects by trauma 
and disease. In this study, a novel calcium polyphosphate scaffold with graded pore structure was 
designed and developed. The gradient scaffold aimed to mimic the bone tissue morphology 
which has four functional layers. The porosity, degradation rate and mechanical properties had 
been investigated. The direct perfusion flow bioreactor was created and used in the study for cell 
culture. The flow rate through each scaffold was 1ml/s. It enabled to enhance cell growth and 
differentiation. After dynamic cell culture, in vitro cells’ behavior had been compared between 
gradient and homogenous scaffolds through MTT method, confocal microscopy and AKP test. 
The gradient and homogenous scaffolds have similar empty space for cells growth. Also the 
results of cell proliferation showed that the amount of cells grown on each scaffold were no 
significant difference. However, the results appeared that the gradient structure impacted cell 
distribution and improved cell differentiation. Micro-PET technology was applied which can 
overcome the limitations of traditional method. It showed that the majority of new forming HA 
was deposited on the 1
st
 and 2
nd
 layer of gradient scaffold. These results proved that the different 
level of cell differentiation and osseous matrix forming between gradient and homogenous 
scaffolds did cause by the gradient structure. Therefore, the gradient scaffold has potential value 
of clinical application.  
In future work, the mechanical strength of the gradient scaffold still needs to be improved 
through finer particles. For the perfusion flow bioreactor, a more durable material is necessary. 
Additionally, a dynamic cell seeding method for gradient scaffold is still worth to study by the 
bioreactor. Finally, the in vivo testing for the gradient scaffold is needed to further study the 
properties of the gradient scaffold. 
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ABSTRACT 
 
INVESTIGATION OF PHYSIOCHEMICAL PROPERTIES OF A NOVEL GRADIENT 
CALCIUM POLYPHOSPHATE BONE SCAFFOLD AND ITS INFLUENCE ON 
CELLULAR BEHAVIOR  
By 
LIANG CHEN 
December 2013  
Advisor: Dr. Weiping Ren 
Major: Biomedical Engineering 
Degree: Master of Science 
A good designed bone scaffold is crucial to bone tissue engineering.  We have developed 
and characterized a novel gradient bone scaffold by combination of Calcium Polyphosphate 
(CPP) with different size of porogen (stearic acids). Compared with homogenous scaffold, the 
gradient bone scaffold with different pore size and porosity can better mimic natural bone 
structure. Directly perfusion flow bioreactor was developed. This 3D dynamic cell culture was 
better mimic the physiological condition for cell growth. It was beneficial to nutrition and 
oxygen delivery throughout the whole scaffold and was able to form shear stress. We wanted to 
investigate the effect of the gradient structure on murine M 3T3 cells’ behavior after dynamic 
cell culture. We hypothesize that the adhesion, proliferation and differentiation of osteogenic 
cells on gradient scaffolds are significantly enhanced, compared to that in homogenous scaffold. 
The porosity, degradation rate and mechanical properties of gradient and homogenous 
scaffolds had been investigated. The total porous volume and degradation rate were similar 
between two scaffolds. While pore size and porosity on 1
st
 and 2
nd
 layer of the gradient scaffold 
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were higher than the homogenous scaffold, which resulted in the mechanical strength of 
homogenous scaffolds was higher than gradient one.  
The cell proliferation (MTT method), cell distribution (confocal microscopy) and cell 
differentiation (Alkaline phosphatase activity) were measured.  Although the level of cell 
proliferation on two kinds of scaffolds was similar, cell distribution and the level of cell 
differentiation were different between two scaffolds. On the gradient scaffold, the level of cell 
differentiation was two times higher than the homogenous scaffold. In order to investigate the 
function of each layer on the gradient scaffold, micro-PET technology was applied. The PET 
image showed that the majority of new forming HA was distributed on the 1
st
 and 2
nd
 layer of 
gradient scaffold. Also tetracycline labeling study showed the crystal structure of HA from the 
gradient scaffold. Therefore, the gradient scaffold with four functional layers (1
st
 and 2
nd
 for cell 
growth, 3
rd
 and 4
th
 for providing mechanical strength) did affect the cells’ distribution and 
enhance the cells’ differentiated which was beneficial for new bone forming. 
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